Colon cancer screening is only effective if you complete the test. With 53,000 Americans expected to die from colon cancer in ...

Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...

The in-vitro colorectal cancer screening tests market is set for significant growth, driven by advancements in diagnostics ...

Cases of colorectal cancer have been rapidly increasing among young adults, so we spoke to a doctor to get some helpful tips.

With colon cancer rates rising, advocates hope a newly approved blood test screening can help more people catch it early.

The Health Promotion Administration (HPA) is to increase public funding for painless colonoscopy screenings for high-risk ...

Expanded eligibility criteria and new tests for national cancer screening programs are to be introduced on Wednesday next ...

According to Guardant’s website, Medicare Part B (Medical Insurance) covers a blood-based biomarker screening test to check for colorectal cancer if the individual is between the ages of 45–85, shows ...

(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...